Nektar Therapeutics (NKTR)
NASDAQ·Healthcare·Biotechnology
$69.11
-2.18%
Mkt Cap $2.16B
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (17 analysts)
$150.17
Range $80.00 – $192.00
Implied Upside
+117.3%
Consensus $150.17 vs current $69.11
NASDAQ·Healthcare·Biotechnology
$69.11
-2.18%
Mkt Cap $2.16B
Buy
5
Hold
2
Sell
0
Price Target (17 analysts)
$150.17
Range $80.00 – $192.00
+117.3%
Consensus $150.17 vs current $69.11